• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抵抗对2型糖尿病一级亲属中非酒精性脂肪性肝病发生的影响。

The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.

作者信息

Hazim Ahmad, Purnamasari Dyah, Kalista Kemal F, Lesmana C Rinaldi A, Nugroho Pringgodigdo

机构信息

Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Indonesia.

Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Indonesia.

出版信息

Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1431-1435. doi: 10.1016/j.dsx.2019.01.058. Epub 2019 Jan 31.

DOI:10.1016/j.dsx.2019.01.058
PMID:31336502
Abstract

BACKGROUND

First degree relatives (FDR) of type 2 diabetes mellitus (T2DM) predisposes individuals to have earlier metabolic and vascular disorders independent of insulin resistance (IR) such as thicker carotid intima media thickness than that of non-FDR. Non-alcoholic fatty liver disease (NAFLD) is the most commonly found chronic liver disease in T2DM which is IR dependent. Studies about NAFLD in FDR of T2DM populations are very limited and inconclusive. It is unclear whether the occurrence of NAFLD in FDR of T2DM is IR dependent or due to genetic vulnerability.

AIMS

The aim of this study is to determine the association between NAFLD and FDR of T2DM.

METHOD AND MATERIALS

A total of 118 young adults (19-39 years old) with normal glucose tolerance (59 FDR of T2DM and age-sex matched 59 non-FDR subjects) were included in this cross-sectional study. Anthropometric measurement and routine laboratory analysis (fasting blood glucose/FBG, HbA1c, lipid profile, alanine aminotransferase (ALT), aspartate transaminase (AST)) were examined. Fatty liver was diagnosed by ultrasonography (US) using standard criteria.

RESULTS

Twenty-six (22,03%) subjects with NAFLD were detected by ultrasound with similar proportion for each group. Low HDL-C level and metabolic syndrome were found higher in FDR group (p = 0.004, OR 3.81, CI95 = 1.47-9,91; p = 0.023, OR 4.28, CI95 = 1.13-16.23). Based on logistic regression analysis, central obesity and obesity had statistically significant influence towards NAFLD.

CONCLUSION

The occurrence of NAFLD in FDR of T2DM was influenced by IR (central obesity and obesity).

摘要

背景

2型糖尿病(T2DM)患者的一级亲属(FDR)易患早期代谢和血管疾病,且独立于胰岛素抵抗(IR),例如其颈动脉内膜中层厚度比非FDR人群更厚。非酒精性脂肪性肝病(NAFLD)是T2DM中最常见的慢性肝病,且与IR相关。关于T2DM人群FDR中NAFLD的研究非常有限且尚无定论。目前尚不清楚T2DM患者FDR中NAFLD的发生是与IR相关还是由于遗传易感性。

目的

本研究旨在确定NAFLD与T2DM患者FDR之间的关联。

方法和材料

本横断面研究共纳入118名糖耐量正常的年轻成年人(19 - 39岁)(59名T2DM患者的FDR以及年龄和性别匹配的59名非FDR受试者)。进行人体测量和常规实验室分析(空腹血糖/FBG、糖化血红蛋白、血脂谱、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST))。采用标准标准通过超声(US)诊断脂肪肝。

结果

超声检查发现26名(22.03%)受试者患有NAFLD,两组比例相似。FDR组的低高密度脂蛋白胆固醇(HDL - C)水平和代谢综合征发生率更高(p = 0.004,比值比(OR)3.81,95%置信区间(CI95)= 1.47 - 9.91;p = 0.023,OR 4.28,CI95 = 1.13 - 16.23)。基于逻辑回归分析,中心性肥胖和肥胖对NAFLD有统计学显著影响。

结论

T2DM患者FDR中NAFLD的发生受IR(中心性肥胖和肥胖)影响。

相似文献

1
The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.胰岛素抵抗对2型糖尿病一级亲属中非酒精性脂肪性肝病发生的影响。
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1431-1435. doi: 10.1016/j.dsx.2019.01.058. Epub 2019 Jan 31.
2
Carotid intima-media thickness among normoglycemia and normotension first-degree relatives of type 2 diabetes mellitus.2型糖尿病正常血糖和正常血压一级亲属的颈动脉内膜中层厚度
Vasc Health Risk Manag. 2019 May 2;15:101-107. doi: 10.2147/VHRM.S195776. eCollection 2019.
3
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
4
Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.2型糖尿病和非酒精性脂肪性肝病患者血清磷脂ω-3多不饱和脂肪酸与胰岛素抵抗
J Diabetes Complications. 2014 Sep-Oct;28(5):711-4. doi: 10.1016/j.jdiacomp.2014.04.008. Epub 2014 Apr 18.
5
First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease.2型糖尿病患者的一级亲属与非酒精性脂肪性肝病风险
Rev Diabet Stud. 2007 Winter;4(4):236-41. doi: 10.1900/RDS.2007.4.236. Epub 2008 Feb 10.
6
The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.2 型糖尿病女性患者非酒精性脂肪肝与骨骼肌质量至内脏脂肪面积比值的关系。
BMC Endocr Disord. 2019 Jul 17;19(1):76. doi: 10.1186/s12902-019-0404-1.
7
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
8
Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus.2型糖尿病一级亲属的胰岛素抵抗及丙氨酸氨基转移酶(ALT)水平
Diabetes Metab Syndr. 2011 Jul-Sep;5(3):143-7. doi: 10.1016/j.dsx.2012.02.011. Epub 2012 Mar 29.
9
The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.通过受控衰减参数测量2型糖尿病与非酒精性脂肪性肝病之间的关系。
Yonsei Med J. 2016 Jul;57(4):885-92. doi: 10.3349/ymj.2016.57.4.885.
10
Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.中国人 2 型糖尿病患者抵抗素+299A/A 基因型与非酒精性脂肪性肝病的关系。
Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.

引用本文的文献

1
Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case-Control Study.甲状腺过氧化物酶抗体升高是2型糖尿病和非酒精性脂肪性肝病患者自身免疫发展的强预测指标:一项病例对照研究。
Diabetes Metab Syndr Obes. 2020 Nov 16;13:4369-4378. doi: 10.2147/DMSO.S280231. eCollection 2020.
2
Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease.二肽基肽酶4抑制剂沙格列汀对非酒精性脂肪性肝病的影响。
Diabetes Metab Syndr Obes. 2020 Oct 6;13:3507-3518. doi: 10.2147/DMSO.S262284. eCollection 2020.